UBS AM’s Tricida, Inc. Common Stock TCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-28,500
Closed -$276K 2787
2022
Q2
$276K Buy
+28,500
New +$271K ﹤0.01% 2497
2021
Q2
Sell
-30,500
Closed -$161K 2791
2021
Q1
$161K Hold
30,500
﹤0.01% 2576
2020
Q4
$215K Hold
30,500
﹤0.01% 2485
2020
Q3
$276K Buy
30,500
+10,709
+54% +$156K ﹤0.01% 2330
2020
Q2
$544K Buy
+19,791
New +$539K ﹤0.01% 2092
2020
Q1
Sell
-5,600
Closed -$211K 2542
2019
Q4
$211K Buy
+5,600
New +$209K ﹤0.01% 2465

Other funds holding TCDA

UBS AM's TCDA Position: Q3 2022 in Review

UBS AM sold out of Tricida, Inc. Common Stock (TCDA) in Q3 2022, closing a stake of 28,500 shares — an estimated $276K sold.

UBS AM first reported a position in TCDA in Q4 2019 and held it in 6 quarters. The position peaked at $544K in Q2 2020. 120 funds tracked by Wall St. Rank hold TCDA as of Q3 2022.

  • UBS AM reported no remaining Tricida, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • UBS AM sold 28,500 Tricida, Inc. Common Stock shares in Q3 2022, an estimated $276K.
  • UBS AM first reported a position in Tricida, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • UBS AM's Tricida, Inc. Common Stock position peaked at $544K in Q2 2020.
  • 120 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q3 2022.

Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.